Japan Vietnam Medical Instrument JSC (JVC) — Capital Reinvestment Ratio

Latest as of December 2022: 4.96x

Japan Vietnam Medical Instrument JSC (JVC) has a Capital Reinvestment Ratio of 4.96x as of December 2022, meaning it reinvests 5% of its operating cash flow (₫2.21 Billion) in capital expenditures (₫10.94 Billion). See free cash flow generation of Japan Vietnam Medical Instrument JSC to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

4.96x
Capex / Operating Cash Flow

Operating Cash Flow

₫2.21 Billion
VND

Capital Expenditures

₫10.94 Billion
VND

Data as of

Dec 2022
Most recent filing

Japan Vietnam Medical Instrument JSC Capital Reinvestment Ratio (2015–2022)

This chart tracks Japan Vietnam Medical Instrument JSC's Capital Reinvestment Ratio across 5 annual periods.

Annual Capital Reinvestment Ratio for Japan Vietnam Medical Instrument JSC (2015–2022)

Year-by-year Capital Reinvestment Ratio for Japan Vietnam Medical Instrument JSC from 2015 to 2022. For live market cap and broader valuation context, see JVC stock market capitalisation.

Year Reinvestment Ratio Operating CF (VND) Capital Expenditures YoY Change
2022 0.75x ₫42.10 Billion ₫31.38 Billion ▲ +132.0%
2021 0.32x ₫127.02 Billion ₫40.81 Billion ▼ -56.1%
2020 0.73x ₫30.71 Billion ₫22.45 Billion ▲ +30.7%
2017 0.56x ₫76.13 Billion ₫42.59 Billion ▼ -97.2%
2015 20.14x ₫2.61 Billion ₫52.56 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow